Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion

Journal of Cellular Biochemistry

Volumn 112, Issue 12, 2011, Pages 3612-3620

  Jang, Kang Won ^a   Lee, Kyung Hye ^b   Kim, Soo Hyuk ^a,c   Jin, Taewon ^a,c   Choi, Eun Young ^a,c   Jeon, Hyun Ju ^a,c   Kim, Eunsuk ^a,c   Han, Ye Sun ^d   Chung, Ji Hyung ^a,c,e  

^a Yonsei University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Konkuk University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Chip; Invasion; NF kappaB; TRAF2

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CARBOXYL TERMINUS OF HSC70 INTERACTING PROTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; BREAST CANCER; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME DEGRADATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEASOMAL DEGRADATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; UBIQUITINATION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; UBIQUITIN-PROTEIN LIGASES;

EID: 80055002519     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23292     Document Type: Article

References (27)

1. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ, Huet G,. 2000. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 18: 171-178. (Pubitemid 32165251)
2. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, Patterson C,. 1999. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19: 4535-4545. (Pubitemid 29242026)
3. Chen ZJ,. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765.
4. Fan M, Park A, Nephew KP,. 2005. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Mol Endocrinol 19: 2901-2914. (Pubitemid 41697710)
5. Habelhah H, Frew IJ, Laine A, Janes PW, Relaix F, Sassoon D, Bowtell DD, Ronai Z,. 2002. Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J 21: 5756-5765. (Pubitemid 35315273)
6. Holst-Hansen C, Johannessen B, Hoyer-Hansen G, Romer J, Ellis V, Brunner N,. 1996. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis 14: 297-307. (Pubitemid 26246575)
7. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T,. 2004. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581. (Pubitemid 39572107)
8. Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K, Nukina N,. 2005. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J Biol Chem 280: 11635-11640. (Pubitemid 40418477)
9. Kajiro M, Hirota R, Nakajima Y, Kawanowa K, So-ma K, Ito I, Yamaguchi Y, Ohie SH, Kobayashi Y, Seino Y, Kawano M, Kawabe Y, Takei H, Hayashi S, Kurosumi M, Murayama A, Kimura K, Yanagisawa J,. 2009. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol 11: 312-319.
10. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G,. 2003. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424: 801-805. (Pubitemid 37021712)
11. Kumar P, Ambasta RK, Veereshwarayya V, Rosen KM, Kosik KS, Band H, Mestril R, Patterson C, Querfurth HW,. 2007. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism. Hum Mol Genet 16: 848-864. (Pubitemid 47061630)
12. Li H, Lin X,. 2008. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. Cytokine 41: 1-8. (Pubitemid 50012147)
13. Li S, Wang L, Berman MA, Zhang Y, Dorf ME,. 2006. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol Cell 24: 497-509. (Pubitemid 350284222)
14. Li HY, Liu H, Wang CH, Zhang JY, Man JH, Gao YF, Zhang PJ, Li WH, Zhao J, Pan X, Zhou T, Gong WL, Li AL, Zhang XM,. 2008. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat Immunol 9: 533-541. (Pubitemid 351560522)
15. Li F, Xie P, Fan Y, Zhang H, Zheng L, Gu D, Patterson C, Li H,. 2009. C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. J Biol Chem 284: 20090-20098.
16. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr., Sledge GW Jr., 1997. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639. (Pubitemid 27281838)
17. Pantel K, Brakenhoff RH,. 2004. Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456. (Pubitemid 38745530)
18. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY,. 2007. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13: 62-69. (Pubitemid 46067387)
19. Prajapati S, Verma U, Yamamoto Y, Kwak YT, Gaynor RB,. 2004. Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity. J Biol Chem 279: 1739-1746. (Pubitemid 38084441)
20. Rangaswami H, Bulbule A, Kundu GC,. 2004. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem 279: 38921-38935. (Pubitemid 39296053)
21. Sliva D, Rizzo MT, English D,. 2002. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277: 3150-3157. (Pubitemid 34953176)
22. Tzimas C, Michailidou G, Arsenakis M, Kieff E, Mosialos G, Hatzivassiliou EG,. 2006. Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-kappaB. Cell Signal 18: 83-92. (Pubitemid 41415717)
23. Wang X, DeFranco DB,. 2005. Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. Mol Endocrinol 19: 1474-1482. (Pubitemid 41002979)
24. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM,. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699. (Pubitemid 39061687)
25. Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, Ashwell JD,. 2005. TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 24: 1886-1898. (Pubitemid 40769507)
26. Xie P, Fan Y, Zhang H, Zhang Y, She M, Gu D, Patterson C, Li H,. 2009. CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol 29: 2398-2408.
27. Yi X, Wei W, Wang SY, Du ZY, Xu YJ, Yu XD,. 2008. Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling. Biochem Pharmacol 75: 1697-1705.